▼ 0.37%
prev close
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Congressional Trades
10
All tracked trades
Members Trading
4
Unique members
Net Activity
+2
6 buys · 4 sells
Members Who Traded This Stock
10 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-10-31 | NVONovo Nordisk A/S Common Stock | Sell | $1,001 - $15,000 | 194d ago | — | |
| 2025-10-30 | NVONovo Nordisk A/S Common Stock | Sell | $1,001 - $15,000 | 194d ago | — | |
| 2025-09-11 | NVONovo Nordisk A/S Common Stock | Buy | $1,001 - $15,000 | 224d ago | — | |
| 2025-08-04 | NVONovo Nordisk A/S Common Stock | Buy | $1,001 - $15,000 | 293d ago | — | |
| 2025-08-04 | NVONovo Nordisk A/S Common Stock | Sell | $1,001 - $15,000 | 264d ago | — | |
| 2025-08-04 | NVONovo Nordisk A/S Common Stock | Buy | $15,001 - $50,000 | 293d ago | — | |
| 2025-06-09 | NVONovo Nordisk A/S Common Stock | Buy | $1,001 - $15,000 | 294d ago | — | |
| 2025-03-27 | NVONovo Nordisk A/S Common Stock | Buy | $15,001 - $50,000 | 418d ago | — | |
| 2024-10-29 | NVONovo Nordisk A/S Common Stock | Buy | $1,001 - $15,000 | 264d ago | — | |
| 2023-07-12 | NVONovo Nordisk A/S Common Stock | Sell | $100,001 - | 1025d ago | — |
2025-10-31
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
194d ago
2025-10-30
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
194d ago
2025-09-11
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
224d ago
2025-08-04
Scott Scott Franklin
NVO
Amount
$1,001 - $15,000
Filed
293d ago
2025-08-04
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
264d ago
2025-08-04
Scott Scott Franklin
NVO
Amount
$15,001 - $50,000
Filed
293d ago
2025-06-09
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
294d ago
2025-03-27
Scott Scott Franklin
NVO
Amount
$15,001 - $50,000
Filed
418d ago
2024-10-29
Valerie Hoyle
NVO
Amount
$1,001 - $15,000
Filed
264d ago
2023-07-12
Daniel Goldman
NVO
Amount
$100,001 -
Filed
1025d ago
Recent News
Powered by Polygon.io
Lilly's New Drug Just Delivered the Largest Weight Loss Ever Seen in a Clinical Trial -- Here's What It Means for Investors
The Smartest Growth Stocks to Buy With $2,000 Right Now
Contrarian Opinion: Novo Nordisk Is A Better Buy Than Eli Lilly Right Now
President Trump Loaded Up on Eli Lilly in Q1. Should You Buy the Obesity Drug Stock Too?
Prediction: These 2 Obesity Drug Stocks Could Double in 2026
Trade Timeline
Congressional activity, newest first
Lisa McClain
2025-10-31 · Sale
$1,001 - $15,000
Lisa McClain
2025-10-30 · Sale
$1,001 - $15,000
Lisa McClain
2025-09-11 · Purchase
$1,001 - $15,000
Scott Scott Franklin
2025-08-04 · Purchase
$1,001 - $15,000
Lisa McClain
2025-08-04 · Sale
$1,001 - $15,000
Scott Scott Franklin
2025-08-04 · Purchase
$15,001 - $50,000
Lisa McClain
2025-06-09 · Purchase
$1,001 - $15,000
Scott Scott Franklin
2025-03-27 · Purchase
$15,001 - $50,000
Valerie Hoyle
2024-10-29 · Purchase
$1,001 - $15,000
Daniel Goldman
2023-07-12 · Sale
$100,001 -